Terms: = Liver cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Clinical Outcome
14 results:
1. Association of anaplastic lymphoma kinase variants and alterations with ensartinib response duration in non-small cell lung cancer.
Hou D; Zheng X; Song W; Liu X; Wang S; Zhou L; Tao X; Lv L; Sun Q; Jin Y; Zhang Z; Ding L; Wu N; Zhao S
Thorac Cancer; 2021 Sep; 12(17):2388-2399. PubMed ID: 34288491
[TBL] [Abstract] [Full Text] [Related]
2. Anaplastic lymphoma kinase tyrosine kinase inhibitor-induced hepatic failure in lung cancer patients: A study of signal mining and analysis of the FDA adverse event reporting system database.
Zhou Z; Wang C; Ying L; Jin M; Zhang F; Shi D
J Clin Pharm Ther; 2021 Aug; 46(4):1148-1154. PubMed ID: 33768534
[TBL] [Abstract] [Full Text] [Related]
3. Differential Efficacy of Pembrolizumab According to Metastatic Sites in Patients With PD-L1 Strongly Positive (TPS ≥ 50%) NSCLC.
Takeyasu Y; Yoshida T; Shibaki R; Matsumoto Y; Goto Y; Kanda S; Horinouchi H; Yamamoto N; Motoi N; Ohe Y
Clin Lung Cancer; 2021 Mar; 22(2):127-133.e3. PubMed ID: 33183972
[TBL] [Abstract] [Full Text] [Related]
4. Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus.
Hoan NX; Khuyen N; Giang DP; Binh MT; Toan NL; Anh DT; Trung NT; Bang MH; Meyer CG; Velavan TP; Song LH
BMC Med Genet; 2019 Dec; 20(1):201. PubMed ID: 31864292
[TBL] [Abstract] [Full Text] [Related]
5. Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study.
Schullian P; Putzer D; Laimer G; Levy E; Bale R
Eur Radiol; 2020 Feb; 30(2):950-960. PubMed ID: 31489472
[TBL] [Abstract] [Full Text] [Related]
6. Safety issues with the alk inhibitors in the treatment of NSCLC: A systematic review.
Kassem L; Shohdy KS; Lasheen S; Abdel-Rahman O; Ali A; Abdel-Malek RR
Crit Rev Oncol Hematol; 2019 Feb; 134():56-64. PubMed ID: 30771874
[TBL] [Abstract] [Full Text] [Related]
7. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related liver Diseases.
Ouda SM; Khairy AM; Sorour AE; Mikhail MN
Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805
[TBL] [Abstract] [Full Text] [Related]
8. Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis.
Castañón E; Rolfo C; Viñal D; López I; Fusco JP; Santisteban M; Martin P; Zubiri L; Echeveste JI; Gil-Bazo I
J Transl Med; 2015 Aug; 13():257. PubMed ID: 26248464
[TBL] [Abstract] [Full Text] [Related]
9. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity.
Dillon ST; Bhasin MK; Feng X; Koh DW; Daoud SS
J Transl Med; 2013 Oct; 11():239. PubMed ID: 24283668
[TBL] [Abstract] [Full Text] [Related]
10. Percutaneous radiofrequency ablation for hepatocellular carcinoma: clinical outcome and safety in elderly patients.
Nishikawa H; Osaki Y; Iguchi E; Takeda H; Ohara Y; Sakamoto A; Hatamaru K; Henmi S; Saito S; Nasu A; Kita R; Kimura T
J Gastrointestin Liver Dis; 2012 Dec; 21(4):397-405. PubMed ID: 23256123
[TBL] [Abstract] [Full Text] [Related]
11. SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study.
Fransvea E; Trerotoli P; Sacco R; Bernabucci V; Milella M; Napoli N; Mazzocca A; Renna E; Quaranta M; Angarano G; Villa E; Antonaci S; Giannelli G
J Viral Hepat; 2012 Oct; 19(10):704-10. PubMed ID: 22967101
[TBL] [Abstract] [Full Text] [Related]
12. An inflammatory myofibroblastic tumor in liver with alk and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features.
Chen ST; Lee JC
Hum Pathol; 2008 Dec; 39(12):1854-8. PubMed ID: 18701132
[TBL] [Abstract] [Full Text] [Related]
13. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
[TBL] [Abstract] [Full Text] [Related]
14. Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases.
Antoniou A; Lovegrove RE; Tilney HS; Heriot AG; John TG; Rees M; Tekkis PP; Welsh FK
Surgery; 2007 Jan; 141(1):9-18. PubMed ID: 17188163
[TBL] [Abstract] [Full Text] [Related]
